Completed Access to Information Requests

Follow:

  • RSS
  • Cite

    Cite

    APA

    Open Government - Government of Canada. (2017, December 10). Completed Access to Information Requests. Retrieved from http://open.canada.ca/en/search/ati?f%5B0%5D=ss_ati_organization_en%3AAtomic%20Energy%20of%20Canada%20Limited&amp%3Bamp%3Bf%5B1%5D=ss_ati_organization_en%3ATransportation%20Safety%20Board%20of%20Canada&amp%3Bamp%3Bf%5B2%5D=ss_ati_organization_en%3APublic%20Health%20Agency%20of%20Canada&amp%3Bamp%3Bati%5B0%5D=ss_ati_organization_en%3ABusiness%20Development%20Bank%20of%20Canada&amp%3Bamp%3Bati%5B1%5D=ss_ati_organization_en%3ACanada%20Border%20Services%20Agency&amp%3Bamp%3Bati%5B2%5D=ss_ati_organization_en%3ACanadian%20Food%20Inspection%20Agency&amp%3Bamp%3Bati%5B3%5D=ss_ati_organization_en%3AMarine%20Atlantic%20Inc&amp%3Bati%5B0%5D=ss_ati_organization_en%3AFisheries%20and%20Oceans%20Canada&ati%5B0%5D=%3ACanada%20Border%20Services%20Agency&ati%5B1%5D=%3AFederal%20Public%20Service%20Health%20Care%20Plan%20Administration%20Authority&ati%5B2%5D=%3AMarch&ati%5B3%5D=%3ANational%20Film%20Board&ati%5B4%5D=%3AOffice%20of%20the%20Intelligence%20Commissioner&ati%5B5%5D=ati_organization_en%3APatented%20Medicine%20Prices%20Review%20Board%20Canada&search_api_fulltext=&sort_by=year&sort_order=DESC&f%5B0%5D=ss_ati_organization_en%3AAtomic%20Energy%20of%20Canada%20Limited&page=2
    MLA

    “Completed Access to Information Requests.” Open Government - Government of Canada, 10 December 2017, http://open.canada.ca/en/search/ati?f%5B0%5D=ss_ati_organization_en%3AAtomic%20Energy%20of%20Canada%20Limited&amp%3Bamp%3Bf%5B1%5D=ss_ati_organization_en%3ATransportation%20Safety%20Board%20of%20Canada&amp%3Bamp%3Bf%5B2%5D=ss_ati_organization_en%3APublic%20Health%20Agency%20of%20Canada&amp%3Bamp%3Bati%5B0%5D=ss_ati_organization_en%3ABusiness%20Development%20Bank%20of%20Canada&amp%3Bamp%3Bati%5B1%5D=ss_ati_organization_en%3ACanada%20Border%20Services%20Agency&amp%3Bamp%3Bati%5B2%5D=ss_ati_organization_en%3ACanadian%20Food%20Inspection%20Agency&amp%3Bamp%3Bati%5B3%5D=ss_ati_organization_en%3AMarine%20Atlantic%20Inc&amp%3Bati%5B0%5D=ss_ati_organization_en%3AFisheries%20and%20Oceans%20Canada&ati%5B0%5D=%3ACanada%20Border%20Services%20Agency&ati%5B1%5D=%3AFederal%20Public%20Service%20Health%20Care%20Plan%20Administration%20Authority&ati%5B2%5D=%3AMarch&ati%5B3%5D=%3ANational%20Film%20Board&ati%5B4%5D=%3AOffice%20of%20the%20Intelligence%20Commissioner&ati%5B5%5D=ati_organization_en%3APatented%20Medicine%20Prices%20Review%20Board%20Canada&search_api_fulltext=&sort_by=year&sort_order=DESC&f%5B0%5D=ss_ati_organization_en%3AAtomic%20Energy%20of%20Canada%20Limited&page=2
    (Report an issue with citation)
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 203 record(s)

Req # A-2023-03268

Part 1: Based on documents disclosed in A-2022-09063, (see PDF pages 67-68), the PMPRB sent a letter to the Minister of Health on or around November 30, 2022. I would like to request a copy of that letter, as well as any response from Health Canada. Part 2: Based on documents disclosed in A-2022-09063, a meeting of the PMPRB occurred on December 5th, 2022 (see PDF page 19 of A-2022-09063). I would like to request the following records related to that meeting: 1. A list of attendees for the meeting. 2. A copy of the calendar invitation for the meeting (regardless of program: Outlook, Google meetup, etc), including any attachments to the invite. 3. The agenda for the meeting. 4. The minutes of the meeting. 5. Any notes taken by participants in the meeting. 6. Any documents distributed or discussed during the meeting (such as handouts or powerpoints). 7. Any emails sent by the participants in the meeting which summarized the meeting or discussed next steps.

Organization: Patented Medicine Prices Review Board Canada

4 page(s)
March 2023

Req # A-2023-03897

We read the article entitled "After pharma lobbying, minister intervened to suspend drug-price reform" published by the media "The Breach": https://breachmedia.ca/after-pharma-lobbying-minister-intervened-tosuspend-drug-price-reform/ We understand that someone from "The Breach" (its author Kelly Crowe or someone else) has requested information from the PMPRB to write the article. We cannot find this request through the archives of the Access to Information and Personal Information Online Request Service. We therefore request all communication, records and documents which were communicated in this request and/or relating to the information behind the aforementioned article which have been provided to The Breach or its employees.

Organization: Patented Medicine Prices Review Board Canada

0 page(s)
March 2023

Req # A-2023-02395

Copies of all correspondence and communications between the (then) acting chairperson of the Patented Medicines Prices Review Board Mélanie Bourassa-Forcier and Innovative Medicines Canada (IMC) between October 1, 2022 and December 5, 2022 regarding the PMPRB's new draft guidelines and the consultation process. Please include all responses to Innovative Medicines Canada (IMC)'s communications/correspondence from the (then) acting chairperson of the Patented Medicines Prices Review Board Mélanie Bourassa-Forcier.

Organization: Patented Medicine Prices Review Board Canada

19 page(s)
February 2023

Req # A-2022-09063

Copies of any emails sent by the Vice-chair regarding any of the following topics: (i) her resignation or intent to resign or the reasons for her resignation. (ii) the draft guidelines. (iii) the consultation process for the draft guidelines. (iv) the impact of the Merck Canada, IMC, and/or Alexion court decisions on the PMPRB, including its draft guidelines. From November 1, 2022 to December 5, 2022.

Organization: Patented Medicine Prices Review Board Canada

58 page(s)
February 2023

Req # A-2022-09228

All correspondence between PMPRB Board members and PMPRB staff pertaining to the October 2022 revised draft Guidelines and the resignation of the PMPRB Acting Chairperson, Mélanie Bourassa-Forcier. “Correspondence” includes written correspondence, call notes, email, text messaging, instant messaging, and any other form of electronic communication.

Organization: Patented Medicine Prices Review Board Canada

134 page(s)
February 2023

Req # A-2022-09229

All correspondence between the former PMPRB Acting Chairperson, Melanie Bourassa-Forcier, and the Minister of Health Jean-Yves Duclos (including the Minister’s staff), or Deputy Minister of Health Stephen Lucas (including the Deputy Minister’s staff), about the PMPRB October 2022 revised draft Guidelines and the resignation of PMPRB Acting Chairperson, Melanie Bourassa-Forcier. “Correspondence” includes written correspondence, call notes, email, text messaging, instant messaging, and any other form of electronic communication.

Organization: Patented Medicine Prices Review Board Canada

10 page(s)
February 2023

Req # A-2022-09230

All correspondence between PMPRB Executive Director Doug Clark and the Minister of Health Jean-Yves Duclos (including the Minister’s staff), or Deputy Minister of Health Stephen Lucas (including the Deputy Minister’s staff), about the PMPRB October 2022 revised draft Guidelines and the resignation of PMPRB Acting Chairperson, Melanie Bourassa-Forcier. “Correspondence” includes written correspondence, call notes, email, text messaging, instant messaging, and any other form of electronic communication.

Organization: Patented Medicine Prices Review Board Canada

11 page(s)
February 2023

Req # A-2022-09231

Copies of all PMPRB Board minutes and materials (briefing materials, presentations, staff recommendations) pertaining to the October 2022 revised draft Guidelines.

Organization: Patented Medicine Prices Review Board Canada

37 page(s)
February 2023

Req # A-2022-09622

All correspondence and emails from the federal Health Minister Jean-Yves Duclos to the Patented Medicines Prices Review Board in the period between October 1, 2022 and December 5, 2022 regarding new draft guidelines and the consultation process and all responses to the federal Minister of Health and Health Canada from the (then) acting chairperson of the Patented Medicines Prices Review Board Mélanie Bourassa-Forcier.

Organization: Patented Medicine Prices Review Board Canada

9 page(s)
February 2023

Req # A-2022-09060

Recordings or transcripts of both of the French language webinars given by the PMPRB on November 8th, 2022, including any audience questions and the PMPRB's responses. Copies of the English and French PowerPoint for the industry specific webinars held on November 8th, 2022.

Organization: Patented Medicine Prices Review Board Canada

134 page(s)
January 2023
Date modified: